These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 26611557)

  • 1. Infection Risk and Safety of Corticosteroid Use.
    Youssef J; Novosad SA; Winthrop KL
    Rheum Dis Clin North Am; 2016 Feb; 42(1):157-76, ix-x. PubMed ID: 26611557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic Infections in Biological Therapy, Risk and Prevention.
    Bryant PA; Baddley JW
    Rheum Dis Clin North Am; 2017 Feb; 43(1):27-41. PubMed ID: 27890172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?
    Liebling M; Rubio E; Ie S
    Expert Rev Respir Med; 2015 Apr; 9(2):171-81. PubMed ID: 25771943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.
    Malpica L; Moll S
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):319-327. PubMed ID: 33275674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
    Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
    Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
    Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
    Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
    Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients.
    Jiang B; Ding H; Zhou L; Chen X; Chen S; Bao C
    Int J Rheum Dis; 2016 Jan; 19(1):38-42. PubMed ID: 26820838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of infections in immune deficiency].
    Lange B; Neumann S; Hirsch HH; Kern WV
    Dtsch Med Wochenschr; 2014 Oct; 139(40):1999-2002. PubMed ID: 25254394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infections during glucocorticoid use].
    Minderhoud TC; van Meer MPA; van Thiel RJ; den Hoed CM; van Daele PLA; Schurink CAM
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Feb; 76(2):191-198. PubMed ID: 28088990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor {alpha}.
    Winthrop KL
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv29-30. PubMed ID: 16239382
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.
    Park JW; Curtis JR; Moon J; Song YW; Kim S; Lee EB
    Ann Rheum Dis; 2018 May; 77(5):644-649. PubMed ID: 29092853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does inhaled corticosteroid treatment result in a secondary immune deficiency predisposing to recurrent infections?
    Bahceciler NN
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):217-20. PubMed ID: 23061612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing and treating biologic-associated opportunistic infections.
    Winthrop KL; Chiller T
    Nat Rev Rheumatol; 2009 Jul; 5(7):405-10. PubMed ID: 19568254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.
    Ma C; Walters B; Fedorak RN
    World J Gastroenterol; 2013 Jun; 19(21):3347-51. PubMed ID: 23745038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infections in patients affected by rheumatologic diseases associated to glucocorticoid use or tumor necrosis factor-alpha inhibitors].
    Fica A
    Rev Chilena Infectol; 2014 Apr; 31(2):181-95. PubMed ID: 24878907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections associated with steroid use.
    Klein NC; Go CH; Cunha BA
    Infect Dis Clin North Am; 2001 Jun; 15(2):423-32, viii. PubMed ID: 11447704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 3. Opportunistic infections].
    Sumida K; Ubara Y
    Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2631-8. PubMed ID: 24400544
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
    Zhang Y; Zheng Y
    Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.